Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO IMS, and SIOG. (2017)

First Author: Hadji P
Attributed to:  The Southampton Women's Survey (SWS) funded by MRC


No abstract provided

Bibliographic Information

Digital Object Identifier:

PubMed Identifier: 28413771

Publication URI:

Type: Journal Article/Review

Volume: 7

Parent Publication: Journal of bone oncology

ISSN: 2212-1366